Effect of TTP488 in patients with mild to moderate Alzheimer's disease

Background: TTP488, an antagonist at the Receptor for Advanced Glycation End products, was http://t.co/3QgVqfNv04

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/3QgVqfNv04